Related Experiment Video
Updated: May 3, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Published on: June 29, 2015
alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive
C Kluft1, H K Nieuwenhuis, D C Rijken
1Gaubius Institute, Leiden, The Netherlands.
Abstract:
alpha 2-Antiplasmin (alpha 2-AP) is a major fibrinolysis inhibitor, whose complete, congenital absence has been found to be associated with a distinct hemorrhagic diathesis. We studied a 15-yr-old male with a hemorrhagic diathesis after trauma from early childhood on. This bleeding tendency was associated with a minimal alpha 2-AP level recorded functionally in the immediate plasmin inhibition test: less than or equal to 4% of normal. However, a normal plasma concentration of alpha 2-AP antigen (83%) was found. His sister (5 yr old) showed similar results (2 and 92%). In their family, eight heterozygotes could be identified by half-normal activity results and normal antigen concentrations. The inheritance pattern is autosomal recessive. On analysis, the alpha 2-AP of the propositus was homogeneous in all respects tested, suggesting a homozygous defect. We designated the abnormal alpha 2-AP as alpha 2-AP Enschede. alpha 2-AP Enschede showed the following characteristics: (a) complete immunological identity with normal alpha 2-AP; (b) normal molecular weight (sodium dodecyl sulfate-polyacrylamide gel electrophoresis); (c) normal alpha-electrophoretic mobility; (d) presence in plasma of both molecular forms excluding an excessive conversion to the less reactive non-plasminogen-binding form; (e) quantitatively normal binding to lys-plasminogen and to immobilized plasminogen kringle 1-3; and (f) normal Factor XIII-mediated binding to fibrin. Functional abnormalities were found in: (i) no inhibition of amidolytic activities of plasmin and trypsin, even on prolonged incubation; (ii) no formation of plasmin-antiplasmin complexes in plasma with plasmin added in excess; and (iii) no inhibition of fibrinolysis by fibrin-bound alpha 2-AP. In the heterozygotes, the presence of abnormal alpha 2-AP did not interfere with several functions of the residual normal alpha 2-AP. One-dimensional peptide mapping showed an abnormal pattern of papain digestion. We conclude that in this family, abnormal antiplasmin molecules, defective in plasmin inhibition but with normal plasminogen-binding properties, have been inherited. The residual plasminogen-binding properties do not protect against a hemorrhagic diathesis.
Insights
Congenital absence of alpha 2-antiplasmin (alpha 2-AP) causes bleeding disorders. This study identifies a novel alpha 2-AP Enschede variant with defective plasmin inhibition but normal plasminogen binding, inherited in an autosomal recessive pattern.
Area of Science:
- Hematology
- Biochemistry
- Genetics
Background:
- Alpha 2-antiplasmin (alpha 2-AP) is a critical inhibitor of fibrinolysis.
- Complete congenital absence of alpha 2-AP is linked to hemorrhagic diathesis.
- This study investigates a family with a bleeding disorder and abnormal alpha 2-AP levels.
Observation:
- A 15-year-old male presented with a lifelong hemorrhagic diathesis.
- He exhibited minimal functional alpha 2-AP activity (≤4% of normal) but normal antigen levels (83%).
- Similar findings were observed in his sister and eight other family members identified as heterozygotes.
Findings:
- The propositus had a homozygous defect, designated alpha 2-AP Enschede, with normal immunological and molecular characteristics but defective plasmin and trypsin inhibition.
- Alpha 2-AP Enschede demonstrated normal plasminogen binding and Factor XIII-mediated fibrin binding.
- Heterozygotes showed normal function of residual normal alpha 2-AP, unaffected by the abnormal variant.
Implications:
- Alpha 2-AP Enschede represents a novel molecular defect in plasmin inhibition.
- Inherited abnormal alpha 2-AP molecules, even with preserved plasminogen binding, do not prevent hemorrhagic diathesis.
- Understanding these defects is crucial for diagnosing and managing bleeding disorders.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cytoskeletal Linker Proteins - Plakins
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

